The influence of metabolic syndrome coexistence on the prognosis of patients with heart failure without atrial fibrillation. Analysis of Polish data from the pilot survey for the ESC Heart Failure Registry
Marcin Wełnicki(Medical University of Warsaw), Artur Mamcarz(Medical University of Warsaw), Dominika Dąbrowska(Medical University of Warsaw), Wiesława B. Duda-Król, Jarosław Dróżdż(Copenhagen University Hospital), Daniel Śliż(Medical University of Warsaw), Tomasz Chomiuk(Medical University of Warsaw), Jowita Szeligowska
Cited by 4
Related Papers
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Myocardial Viability and Survival in Ischemic Left Ventricular Dysfunction
|New England Journal of Medicine|2011|877
European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-Year Follow-Up Outcomes and Differences Across Regions
|European Journal of Heart Failure|2016|781
In-Hospital and 1-Year Mortality Associated with Diabetes in Patients with Acute Heart Failure: Results from the ESC-HFA Heart Failure Long-Term Registry
|European Journal of Heart Failure|2016|171